Key Highlights
- Second-quarter net sales reached $1.819 billion, up 4% year over year with matching organic growth, and adjusted EPS surged 48% to $1.88.
- The Healthcare & Water Technologies segment grew sales 5% to $856 million, and Diversified Industrials grew 3% to $963 million.
- The company raised full-year 2026 guidance to net sales of $7.16 billion to $7.19 billion and adjusted EPS of $7.17 to $7.32.
- Shares gained as DuPont announced a $250 million buyback for the third quarter under a broader $2 billion authorization.
DuPont de Nemours (NYSE:DD), the storied materials-science company, gained after completing a major transformation, spinning off its electronics Business and reshaping itself into a leaner, more focused enterprise centered on healthcare, water and industrial markets. With sales growing, Earnings surging and guidance raised, the question is whether the next move could be even bigger for the reconstituted DuPont.
Following the November 2025 separation of its electronics business into a standalone company called Qnity, DuPont now operates two primary divisions: Healthcare & Water Technologies, and Diversified Industrials. The company provides specialized materials and solutions across healthcare, water infrastructure, construction and industrial end markets.
Latest Developments
In its second-quarter 2026 results, DuPont reported net sales of $1.819 billion, up 4% year over year with matching organic growth, and operating EBITDA of $448 million (up 6%) at a 24.6% margin. Adjusted EPS surged 48% to $1.88. Its Healthcare & Water Technologies segment grew sales 5% to $856 million, and Diversified Industrials grew 3% to $963 million. The company raised full-year 2026 guidance to net sales of $7.16 billion to $7.19 billion, operating EBITDA of $1.75 billion to $1.77 billion and adjusted EPS of $7.17 to $7.32. It also announced a $250 million buyback for the third quarter under a broader $2 billion authorization, and it had divested its Aramids business in April 2026.
Financial and Business Position
The Qnity Spinoff and other portfolio moves have transformed DuPont into a more focused company with strong margins and improving growth, and the raised guidance reflects confidence in that trajectory. The sharp increase in adjusted EPS points to the earnings power of the streamlined portfolio, and the substantial buyback authorization underscores the company's commitment to returning capital. Its exposure to healthcare, water and industrial markets provides diversified end-market demand, though it remains subject to broader industrial and economic cycles.
Stock-Market Context
The stock carries a favorable analyst rating, reflecting optimism about the reshaped company and its momentum. The bigger-move case rests on the focused portfolio driving continued sales and Margin growth, earnings expansion and Capital returns; the cautionary case is that DuPont's industrial and construction exposures are cyclical, that macroeconomic conditions could soften demand, and that the benefits of the transformation may already be partly reflected in the shares.
What Investors Should Watch
Investors may focus on Organic Sales and margin trends across the Healthcare & Water and Diversified Industrials segments, execution against the raised full-year guidance, the pace of share repurchases under the $2 billion authorization, and Demand across its healthcare, water and industrial end markets. Evidence that the streamlined DuPont can sustain growth and margin expansion while returning capital would do the most to confirm that its next move could be even bigger.
DuPont's transformation into a leaner, more focused enterprise reflects a broader strategy that has played out across the industrials and materials sector, where conglomerates have separated businesses to allow each to be valued and managed on its own merits. The quarter's results, including solid organic sales growth, expanding margins and a striking increase in adjusted EPS, suggest the reconstituted company has genuine earnings power. For investors, the bigger-move case rests on the focused portfolio sustaining its growth and margin momentum, with capital returns amplifying per-share results.


_11_16_2026_20_28_42_241342.jpg)

_11_16_2026_20_30_21_403685.jpg)

Please wait processing your request...